Open AccessP570: REAL‐WORLD EFFICACY OUTCOMES OF VENETOCLAX PLUS AZACITIDINE VS INTENSIVE CHEMOTHERAPY FOR INDUCTION THERAPY IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
Author(s) -
Zeidan A. M.,
Pollyea D. A.,
Borate U.,
Vasconcelos A.,
Potluri R.,
Rotter D.,
Kiendrebeogo Z.,
Gaugler L.,
Bonifacio G.,
Prebet T.,
Chen C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845168.01159.c0
Subject(s) - venetoclax , medicine , azacitidine , myeloid leukemia , oncology , induction chemotherapy , regimen , propensity score matching , retrospective cohort study , chemotherapy , leukemia , chronic lymphocytic leukemia , biochemistry , gene expression , dna methylation , gene , chemistry